We demonstrate that RFX6 expression is transcriptionally reprogrammed, likely due to an AR binding site gain at the PCa risk‐associated rs339331/6q22 locus over human prostate tumorigenesis. The gene discussed is AR; the disease is posterior cortical atrophy.